Crigler-Najjar syndrome synonyms

TL;DR: Crigler-Najjar syndrome is officially classified into two types, Type I and Type II, and is also historically referred to as congenital non-hemolytic jaundice. While older literature may use terms like "familial non-hemolytic jaundice with kernicterus," the medical community now exclusively uses the term Crigler-Najjar syndrome to ensure accurate diagnosis and treatment planning.

What are the primary synonyms and official names for Crigler-Najjar syndrome?

In medical literature and official databases, Crigler-Najjar syndrome is the standard nomenclature. However, you may encounter several alternative names depending on the age of the medical record or the specific classification system used. The most common synonym is congenital non-hemolytic jaundice, which describes the clinical presentation of the condition. In older clinical papers, you might see it referred to as familial non-hemolytic jaundice or, specifically for Type I, familial non-hemolytic jaundice with kernicterus. Because Crigler-Najjar syndrome is a rare genetic disorder, understanding these synonyms is vital when reviewing historical medical records or researching the condition in archival databases.

How is the condition classified in international medical systems?

Medical professionals and researchers categorize Crigler-Najjar syndrome based on the severity of the enzyme deficiency (UDP-glucuronosyltransferase). The major classification systems utilize the following identifiers:

• Orphanet: Recognized as ORPHA207 (Type I) and ORPHA208 (Type II).


• OMIM (Online Mendelian Inheritance in Man): Listed under #218800 (Type I) and #606785 (Type II).


• ICD-10/11: Categorized under congenital non-hemolytic jaundice codes (e.g., E80.5).

Why does Crigler-Najjar syndrome have multiple historical names?

The naming of Crigler-Najjar syndrome reflects the history of its discovery by pediatricians John Crigler and Victor Najjar in 1952. Before the underlying genetic mechanism—mutations in the UGT1A1 gene—was fully understood, the condition was often described purely by its clinical symptoms, such as severe jaundice appearing shortly after birth. As our understanding of the metabolic pathways involved in bilirubin conjugation improved, the medical community moved away from descriptive names like "familial non-hemolytic jaundice" toward the eponymous Crigler-Najjar syndrome to differentiate it from other causes of neonatal jaundice. Today, the split into Type I (complete deficiency) and Type II (partial deficiency, historically sometimes called Arias syndrome) provides the most clinical utility.

How can patients navigate these different terms?

When communicating with your healthcare team, using the term Crigler-Najjar syndrome is the most effective way to ensure clarity. If you are reviewing older records that use terms like "congenital non-hemolytic jaundice," you can ask your physician to clarify whether it refers to Type I or Type II. At DiseaseMaps.org, our community of 35 members living with Crigler-Najjar syndrome often shares how they use these specific medical terms to advocate for better care and coordinate with specialists who understand the nuances of the condition.

Next steps

• Consult a hepatologist or a metabolic disease specialist to confirm your specific subtype.


• Request a copy of your genetic testing report to verify the UGT1A1 mutation.


• Join the DiseaseMaps.org community to connect with other families navigating the complexities of this diagnosis.


• Maintain an up-to-date medical summary that includes the official Crigler-Najjar syndrome diagnosis to provide to new specialists.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• Orphanet: Rare Disease Database (ORPHA207)


• NIH Genetic and Rare Diseases Information Center (GARD)


• OMIM: Online Mendelian Inheritance in Man (Entry #218800)


• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)